Multisystem Inflammatory Syndrome in Children and COVID-19 Infections

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused COVID-19 and multisystem inflammatory syndrome in children (MIS-C). This article reviews emerging literature on long-term implications for children, highlighting the school nurse

Area of Science:

  • Pediatric infectious diseases
  • Public health
  • Epidemiology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, has led to a new pediatric condition, multisystem inflammatory syndrome in children (MIS-C).
  • MIS-C presents as a Kawasaki-like inflammatory syndrome in children, emerging concurrently with the pandemic.
  • Limited data exists on the long-term health and developmental effects of both COVID-19 and MIS-C in pediatric populations.

Purpose of the Study:

  • To provide a comprehensive overview of the current scientific literature on COVID-19 and MIS-C in children.
  • To synthesize emerging information regarding the long-term implications of these conditions.
  • To underscore the critical role of school nurses in monitoring children's health trends.

Main Methods:

  • Literature review of recent studies on COVID-19 and MIS-C in children.
  • Analysis of emerging data on long-term outcomes.
  • Exploration of the school nurse's role in surveillance.

Main Results:

  • Information on long-term implications of COVID-19 and MIS-C in children is still developing.
  • School nurses are uniquely positioned to observe and report on developmental and health trends in affected children.
  • Early identification of trends by school nurses can aid in understanding long-term impacts.

Conclusions:

  • Continued research is vital to understand the long-term consequences of COVID-19 and MIS-C in children.
  • School nurses play a crucial role in the ongoing monitoring and early detection of health changes in pediatric populations post-infection.
  • Collaboration and data sharing are essential for comprehensive management and care of children affected by these conditions.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
70
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
43
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.3K